MTRX (NASDAQ) Form 144: Director signals 36,000‑share resale notice
Rhea-AI Filing Summary
MTRX submitted a Form 144 notice indicating proposed sales of 36,000 shares of Common Stock with an aggregate value of $437,760.00. The filing lists 28,133,850 shares outstanding as of 05/08/2026. Several past equity awards and one open‑market purchase are itemized with individual share counts and dates.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies an intended sale of 36,000 common shares.
The filing lists $437,760.00 alongside 05/08/2026 and an outstanding share count of 28,133,850. This is a regulatory notice to permit resale under Rule 144; timing and actual sale execution are not specified.
Cash‑flow treatment and purchaser identity are not disclosed in the excerpt; subsequent transaction reports would show completed dispositions if and when sales occur.
Listed equity awards and a prior open‑market purchase appear as source holdings.
The excerpt lists stock award grants dated 08/24/2022 (8,489 shares), 08/26/2022 (9,043 shares), 08/27/2022 (8,345 shares), 08/30/2022 (9,225 shares), and an open‑market purchase on 12/22/2021 (898 shares). These entries document origins of the shares the filer may sell.
Whether sales convert compensation into cash depends on the filer’s execution; further filings will clarify outcomes.